Overview

Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Study to test the effectiveness of a marketed drug in the treatment of migraine-associated nausea.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Rizatriptan